Health ❯ Clinical Trials

Phase 1 Trials

Safety and Efficacy Drug Testing Gene Therapy Trials Chronic Weight Management Drug Development Patient Monitoring ADC Clinical Studies Drug Evaluation Vaccine Development Vaccine Trials Oncology Trials DREAMM-9 Trial Drug Mechanism Cancer Treatments Patient Recruitment Animal Models Vaccine Safety Weight Loss Medications

Novartis to Acquire Excellergy in Up to $2 Billion Deal for Next-Gen Anti-IgE

The move backs a design that strips IgE from immune cells to shut down allergic signaling faster.

Astellas–Vir Prostate Cancer Alliance Launches With New Data as VIR Stock Surges

Pfizer Licenses Early-Stage Oral GLP-1 From YaoPharma in Up to $2 Billion Deal

Janux Plunges on Mixed Phase 1 Prostate Cancer Data for JANX007

Single-Infusion CRISPR Therapy Lowers LDL and Triglycerides in First Human Trial

Sanofi Signs $1.15 Billion Deal to Acquire Vicebio’s Molecular Clamp Respiratory Vaccine Platform

Engineered Gut Microbe for Kidney Stones Gets Triple Safeguard After Mutation Concerns